New 2025 Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Jan Vydra Journal Bone Marrow Transplant.
New 2025 Non-T-Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP/EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Am J Hematol.
New 2025 The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations Group Acute Leukemia Working Party (ALWP) 1st listed author Iman Abou Dalle Journal Bone Marrow Transplant.
New 2025 Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Avichai Shimoni Journal Br J Haematol.
New 2025 Superior GVHD-Free, Relapse-Free Survival for Haploidentical Transplant With PTCy Than Matched Unrelated Donor for AML Patients Transplanted in Second Complete Remission: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Yishan Ye Journal Am J Hematol.
New 2025 Older matched sibling donor vs young haploidentical donor for older patients with acute myeloid leukemia Group Acute Leukemia Working Party (ALWP) 1st listed author Xavier Poiré Journal Blood Adv.
New 2025 Impact of pre-transplant induction cycles on post-transplant outcomes in patients with ALL: a study from the ALWP EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Juan Montoro Journal Bone Marrow Transplant.
New 2025 Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Allografted in First Remission: From EBMT ALWP Group Acute Leukemia Working Party (ALWP) 1st listed author Ali Bazarbachi Journal Am J Hematol.
New 2025 TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated versus haploidentical donor transplants in a multi-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) Global Committee 1st listed author Lin Li Journal Haematologica.
New 2025 The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide Group Acute Leukemia Working Party (ALWP) 1st listed author Alexandros Spyridonidis Journal Bone Marrow Transplant.
2025 Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Jan Vydra Journal Bone Marrow Transplant.
2025 Frequency and impact of somatic co-occurring mutations on post-transplant outcomes in acute myeloid leukemia: a multicenter registry analysis on behalf of the EBMT ALWP Group Acute Leukemia Working Party (ALWP) 1st listed author Ali Bazarbachi Journal Bone Marrow Transplant.